Aging
Navigate
Back to articleFigure 2(2 of 7)
100%
Figure 2
Figure 2.Rolipram reverses metabolic disorders. (A) Body weight and (B) food intake in normal and presenile mice, with or without rolipram treatment. (C) Serum total cholesterol level and (D) hepatic adiponectin levels in rolipram-treated and untreated presenile mice.
Figure 2 — Phosphodiesterase 4 inhibitor activates AMPK-SIRT6 pathway to prevent aging-related adipose deposition induced by metabolic disorder | Aging